Analysis of Leukocyte Behaviors on Microfluidic Chips

Abstract

The orchestration of massive leukocytes in the immune system protects humans from invading pathogens and abnormal cells in the body. So far, researches focusing on leukocyte behaviors are performed based on both in vivo and in vitro models. The in vivo animal models are usually less controllable due to their extreme complexity and nonignorable species issue. Therefore, many researchers turn to in vitro models. With the advances in micro/nanofabrication, the microfluidic chip has emerged as a novel platform for model construction in multiple biomedical research fields. Specifically, the microfluidic chip is used to study leukocyte behaviors, due to its incomparable advantages in high throughput, precise control, and flexible integration. Moreover, the small size of the microstructures on the microfluidic chip can better mimic the native microenvironment of leukocytes, which contributes to a more reliable recapitulation. Herein are reviewed the recent advances in microfluidic chip–based leukocyte behavior analysis to provide an overview of this field. Detailed discussions are specifically focused on host defense against pathogens, immunodiagnosis, and immunotherapy studies on microfluidic chips. Finally, the current technical challenges are discussed, as well as possible innovations in this field to improve the related applications.

Microfluidics for Peptidomics, Proteomics, and Cell Analysis

“…Microfluidics (MF) is a relatively new branch of science and microengineering that deals with manipulating fluids in microchannels with at least one dimension of 1 to 100 micrometers [ 1 , 2 ], as shown in Figure 1 . Scientists consider it a new discipline not only because of the recent emergence of microfluidic (MF) devices that can implement rapid solutions to complex analytical problems at the microscale but also because the physical principles of fluid flow at such small length scales differ from those in macrosystems [ 3 ]. MF spans several disciplines—physical and chemical sciences, micromechanics, electronics, and mechanical engineering.…”

Microfluidic technologies for immunotherapy studies on solid tumours

“…4 By allowing greater control of fluid volumes, culture conditions, surface chemistry and stimuli exposure, the unique characteristics of the technology make microfluidics an ideal platform for the development and testing of immunotherapeutic agents. [5][6][7] Microfluidic technologies are often used to test anti-cancer therapies on liquid, 8,9 and solid tumours, such as spheroids, organoids 10 and tumour tissue slices. 11 They are also used to study immune cell behaviour, interaction and migration in a reconstructed tumour model, but have not been extensively used for efficacy studies of cancer immunotherapy.…”

Self-crosslinking hyaluronic acid–carboxymethylcellulose hydrogel enhances multilayered 3D-printed construct shape integrity and mechanical stability for soft tissue engineering

“…3D-bioprinting technology has been revolutionizing tissue-engineering and in vitro organ development research [1][2][3][4][5][6][7]. Among the different methods 5 Author to whom any correspondence should be addressed.…”

“…3D-bioprinting technology has been revolutionizing tissue-engineering and in vitro organ development research [1][2][3][4][5][6][7]. Among the different methods 5 Author to whom any correspondence should be addressed. of 3D bioprinting, extrusion 3D printing is widely used, considered as an additive manufacturing approach [8][9][10][11][12].…”